Donor Recipient Kidney Function Following Open Surgical vs. Laparoscopic Kidney Donation
Infrared Image Guided Minimally Invasive Live Donor Kidney Donation for Kidney Transplantation
2 other identifiers
observational
40
1 country
1
Brief Summary
This study will evaluate the differences between open surgical kidney donation and laparoscopic kidney donation on kidney donors and recipients. Both procedures are standard surgeries used to remove kidneys for donation, and they are done equally often. Open surgical kidney donation involves removing the donor kidney through a 3- to 5-inch surgical incision. Laparoscopic donation involves making several small holes in the skin and removing the kidney through a larger hole, while directly watching the kidney with a camera. The study will correlate the effects of both procedures with donor and recipient kidney function, urine output, post-operative pain, and return to work after surgery. Adults without kidney disease who are willing to donate a kidney to a patient enrolled in a clinical transplant protocol at the NIH Clinical Center may be eligible for this study. Donors and recipients must be enrolled in the NIDDK protocol, Live Donor Renal Donation for Allotransplantation (protocol #99-DK-0107). Donors and patients undergo the following procedures:
- Infrared imaging (measurement of small differences in temperature using a special camera) during surgery to look at blood flow to the kidney during the operation (both donor and recipient surgical procedures). The pictures provide images of the blood vessels in the kidney and measure how the blood flow changes.
- Kidney biopsy (removal of a small piece of kidney tissue). The patient's failed kidney is biopsied once during transplant surgery when it is removed. The donor's kidney is biopsied twice - once during surgery to remove the organ from the donor and again after transplant into the recipient.
- Evaluations after surgery of post-operative urine output, blood pressure, and pain, and length of hospital stay and return to work.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Dec 2004
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 23, 2004
CompletedFirst Submitted
Initial submission to the registry
December 31, 2004
CompletedFirst Posted
Study publicly available on registry
January 3, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
June 17, 2008
CompletedJuly 2, 2017
June 17, 2008
December 31, 2004
June 30, 2017
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Patients enrolled in the Live Donor Renal Donation for Allotransplantation 99-DK-0107.
You may not qualify if:
- Patients ineligible for this protocol will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (1)
Tarantino A. Why should we implement living donation in renal transplantation? Clin Nephrol. 2000 Apr;53(4):suppl 55-63.
PMID: 10809438BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
December 31, 2004
First Posted
January 3, 2005
Study Start
December 23, 2004
Study Completion
June 17, 2008
Last Updated
July 2, 2017
Record last verified: 2008-06-17